These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23308112)

  • 1. Synthetic cationic peptide IDR-1018 modulates human macrophage differentiation.
    Pena OM; Afacan N; Pistolic J; Chen C; Madera L; Falsafi R; Fjell CD; Hancock RE
    PLoS One; 2013; 8(1):e52449. PubMed ID: 23308112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate defense regulator IDR-1018 activates human mast cells through G protein-, phospholipase C-, MAPK- and NF-ĸB-sensitive pathways.
    Yanashima K; Chieosilapatham P; Yoshimoto E; Okumura K; Ogawa H; Niyonsaba F
    Immunol Res; 2017 Aug; 65(4):920-931. PubMed ID: 28653285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory Peptide IDR-1018 Decreases Implant Infection and Preserves Osseointegration.
    Choe H; Narayanan AS; Gandhi DA; Weinberg A; Marcus RE; Lee Z; Bonomo RA; Greenfield EM
    Clin Orthop Relat Res; 2015 Sep; 473(9):2898-907. PubMed ID: 25953690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment.
    Nijnik A; Madera L; Ma S; Waldbrook M; Elliott MR; Easton DM; Mayer ML; Mullaly SC; Kindrachuk J; Jenssen H; Hancock RE
    J Immunol; 2010 Mar; 184(5):2539-50. PubMed ID: 20107187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic immunomodulatory peptide IDR-1002 enhances monocyte migration and adhesion on fibronectin.
    Madera L; Hancock RE
    J Innate Immun; 2012; 4(5-6):553-68. PubMed ID: 22722749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of interleukin-1β-induced inflammatory responses by a synthetic cationic innate defence regulator peptide, IDR-1002, in synovial fibroblasts.
    Turner-Brannen E; Choi KY; Lippert DN; Cortens JP; Hancock RE; El-Gabalawy H; Mookherjee N
    Arthritis Res Ther; 2011 Aug; 13(4):R129. PubMed ID: 21835002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-infective peptide IDR-1002 augments monocyte chemotaxis towards CCR5 chemokines.
    Madera L; Hancock RE
    Biochem Biophys Res Commun; 2015 Aug; 464(3):800-6. PubMed ID: 26168734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human placental mesenchymal stem cells (pMSCs) play a role as immune suppressive cells by shifting macrophage differentiation from inflammatory M1 to anti-inflammatory M2 macrophages.
    Abumaree MH; Al Jumah MA; Kalionis B; Jawdat D; Al Khaldi A; Abomaray FM; Fatani AS; Chamley LW; Knawy BA
    Stem Cell Rev Rep; 2013 Oct; 9(5):620-41. PubMed ID: 23812784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The innate defense regulator peptides IDR-HH2, IDR-1002, and IDR-1018 modulate human neutrophil functions.
    Niyonsaba F; Madera L; Afacan N; Okumura K; Ogawa H; Hancock RE
    J Leukoc Biol; 2013 Jul; 94(1):159-70. PubMed ID: 23616580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate defense regulator peptide 1018 in wound healing and wound infection.
    Steinstraesser L; Hirsch T; Schulte M; Kueckelhaus M; Jacobsen F; Mersch EA; Stricker I; Afacan N; Jenssen H; Hancock RE; Kindrachuk J
    PLoS One; 2012; 7(8):e39373. PubMed ID: 22879874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction by innate defence regulator peptide 1018 of pro-angiogenic molecules and endothelial cell migration in a high glucose environment.
    Marin-Luevano P; Trujillo V; Rodriguez-Carlos A; González-Curiel I; Enciso-Moreno JA; Hancock REW; Rivas-Santiago B
    Peptides; 2018 Mar; 101():135-144. PubMed ID: 29353019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the immune response by the host defense peptide IDR-1002 in chicken hepatic cell culture.
    Sebők C; Tráj P; Mackei M; Márton RA; Vörösházi J; Kemény Á; Neogrády Z; Mátis G
    Sci Rep; 2023 Sep; 13(1):14530. PubMed ID: 37666888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ability of innate defence regulator peptides IDR-1002, IDR-HH2 and IDR-1018 to protect against Mycobacterium tuberculosis infections in animal models.
    Rivas-Santiago B; Castañeda-Delgado JE; Rivas Santiago CE; Waldbrook M; González-Curiel I; León-Contreras JC; Enciso-Moreno JA; del Villar V; Mendez-Ramos J; Hancock RE; Hernandez-Pando R
    PLoS One; 2013; 8(3):e59119. PubMed ID: 23555622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human amnion favours tissue repair by inducing the M1-to-M2 switch and enhancing M2 macrophage features.
    Magatti M; Vertua E; De Munari S; Caro M; Caruso M; Silini A; Delgado M; Parolini O
    J Tissue Eng Regen Med; 2017 Oct; 11(10):2895-2911. PubMed ID: 27396853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural antiviral compound silvestrol modulates human monocyte-derived macrophages and dendritic cells.
    Blum L; Geisslinger G; Parnham MJ; Grünweller A; Schiffmann S
    J Cell Mol Med; 2020 Jun; 24(12):6988-6999. PubMed ID: 32374474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide IDR-1018: modulating the immune system and targeting bacterial biofilms to treat antibiotic-resistant bacterial infections.
    Mansour SC; de la Fuente-Núñez C; Hancock RE
    J Pept Sci; 2015 May; 21(5):323-9. PubMed ID: 25358509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathelicidin-WA polarizes E. coli K88-induced M1 macrophage to M2-like macrophage in RAW264.7 cells.
    Chen S; Lu Z; Wang F; Wang Y
    Int Immunopharmacol; 2018 Jan; 54():52-59. PubMed ID: 29101873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LL-37 immunomodulatory activity during Mycobacterium tuberculosis infection in macrophages.
    Torres-Juarez F; Cardenas-Vargas A; Montoya-Rosales A; González-Curiel I; Garcia-Hernandez MH; Enciso-Moreno JA; Hancock RE; Rivas-Santiago B
    Infect Immun; 2015 Dec; 83(12):4495-503. PubMed ID: 26351280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An anti-infective peptide that selectively modulates the innate immune response.
    Scott MG; Dullaghan E; Mookherjee N; Glavas N; Waldbrook M; Thompson A; Wang A; Lee K; Doria S; Hamill P; Yu JJ; Li Y; Donini O; Guarna MM; Finlay BB; North JR; Hancock RE
    Nat Biotechnol; 2007 Apr; 25(4):465-72. PubMed ID: 17384586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Anti-Infective Peptide BCCY-1 With Immunomodulatory Activities.
    Cai J; Cui X; Wang X; You L; Ji C; Cao Y
    Front Immunol; 2021; 12():713960. PubMed ID: 34367182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.